Suricog Overview

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.31M

  • Investors
  • 4

Suricog General Information

Description

Developer of digital vision platform designed to approach all the functions of vision from a digital angle using a human-machine interface. The company's technology offers an interactive eye-tracker that exploits the potential of eye-movement interaction, enabling clients to improve their health and well-being.

Contact Information

Website
www.suricog.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 130 rue de Lourmel
  • 75015 Paris
  • France
+33 01
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Devices and Supplies
Vertical(s)
TMT
Corporate Office
  • 130 rue de Lourmel
  • 75015 Paris
  • France
+33 01

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Suricog Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 22-Feb-2024 $2.31M Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Angel (individual) 01-Jan-2016 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2012 Completed Generating Revenue
To view Suricog’s complete valuation and funding history, request access »

Suricog Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary
Ordinary 204 $10.799012 $1746.9 $1746.9 1x $1746.9 7.74%
Ordinary 16 $10.799012 $1349.88 $1349.88 1x $1349.88 0.61%
To view Suricog’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Suricog Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • Pending

  • Expiring in next 12 mo

Suricog Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3350671-A1 Method for determining an ophthalmological parameter Active 18-Sep-2015
EP-3350671-B1 Method for determining an ophthalmological parameter Active 18-Sep-2015
EP-3068282-A1 Method and system for determining endophenotypes characteristic of an illness, such as schizophrenia Inactive 14-Nov-2013
EP-3058444-A1 Method of interaction by gaze and associated device Inactive 14-Oct-2013
US-20150305661-A1 Method and system for collecting a return saccade parameter during a visual test, and use for diagnosing an oculomotor disorder Inactive 30-Nov-2012 A61B5/163
To view Suricog’s complete patent history, request access »

Suricog Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Suricog Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
EyeFocus Accelerator Accelerator/Incubator
Agoranov Accelerator/Incubator
Generate (Paris) Accelerator/Incubator
Plant 4.0 Startup Incubator Accelerator/Incubator
To view Suricog’s complete investors history, request access »

Suricog Acquisitions (1)

Suricog’s most recent deal was a Merger/Acquisition with EyeBrain. The deal was made on 18-Dec-2015.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
EyeBrain 18-Dec-2015 Merger/Acquisition Diagnostic Equipment
To view Suricog’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Suricog FAQs

  • Where is Suricog headquartered?

    Suricog is headquartered in Paris, France.

  • What is the size of Suricog?

    Suricog has 20 total employees.

  • What industry is Suricog in?

    Suricog’s primary industry is Other Healthcare Technology Systems.

  • Is Suricog a private or public company?

    Suricog is a Private company.

  • What is the current valuation of Suricog?

    The current valuation of Suricog is .

  • What is Suricog’s current revenue?

    The current revenue for Suricog is .

  • How much funding has Suricog raised over time?

    Suricog has raised $3.51M.

  • Who are Suricog’s investors?

    EyeFocus Accelerator, Agoranov, Generate (Paris), and Plant 4.0 Startup Incubator have invested in Suricog.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »